Can-Fite BioPharma Ltd. (TLV:CANF)

Can-Fite BioPharma Statistics

Total Valuation

TLV:CANF has a market cap or net worth of ILS 47.32 million. The enterprise value is 25.87 million.

Market Cap	47.32M
Enterprise Value	25.87M

Important Dates

The next estimated earnings date is Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

TLV:CANF has 4.73 billion shares outstanding. The number of shares has increased by 87.11% in one year.

Current Share Class	4.73B
Shares Outstanding	4.73B
Shares Change (YoY)	+87.11%
Shares Change (QoQ)	+34.83%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	9.25%
Float	4.73B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.08
PB Ratio	3.36
P/TBV Ratio	3.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.87
EV / Sales	13.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.92

Financial Position

The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.02.

Current Ratio	3.60
Quick Ratio	3.05
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -264.12% and return on invested capital (ROIC) is -163.99%.

Return on Equity (ROE)	-264.12%
Return on Assets (ROA)	-81.86%
Return on Invested Capital (ROIC)	-163.99%
Return on Capital Employed (ROCE)	-159.54%
Revenue Per Employee	377,362
Profits Per Employee	-5.93M
Employee Count	5
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.54% in the last 52 weeks. The beta is 0.08, so TLV:CANF's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	-61.54%
50-Day Moving Average	1.03
200-Day Moving Average	1.53
Relative Strength Index (RSI)	27.69
Average Volume (20 Days)	1,476,947

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TLV:CANF had revenue of ILS 1.89 million and -29.65 million in losses. Loss per share was -0.01.

Revenue	1.89M
Gross Profit	1.89M
Operating Income	-30.10M
Pretax Income	-29.65M
Net Income	-29.65M
EBITDA	-30.00M
EBIT	-30.10M
Loss Per Share	-0.01

Balance Sheet

The company has 21.75 million in cash and 303,237 in debt, giving a net cash position of 21.45 million or 0.00 per share.

Cash & Cash Equivalents	21.75M
Total Debt	303,237
Net Cash	21.45M
Net Cash Per Share	0.00
Equity (Book Value)	14.10M
Book Value Per Share	0.00
Working Capital	18.54M

Cash Flow

In the last 12 months, operating cash flow was -28.14 million and capital expenditures -6,739, giving a free cash flow of -28.15 million.

Operating Cash Flow	-28.14M
Capital Expenditures	-6,739
Free Cash Flow	-28.15M
FCF Per Share	-0.01

Margins

Gross Margin	100.00%
Operating Margin	-1,595.36%
Pretax Margin	-1,571.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:CANF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-87.11%
Shareholder Yield	n/a
Earnings Yield	-62.65%
FCF Yield	-59.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 12, 2013. It was a reverse split with a ratio of 0.04.

Last Split Date	May 12, 2013
Split Type	Reverse
Split Ratio	0.04

Scores

TLV:CANF has an Altman Z-Score of -31.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-31.24
Piotroski F-Score	3